-
Let Us Review Your Case
-
Recent Posts
- Class Action Lawsuits Against Red Light Cameras Keep Coming
- Dallas Litigation Lawyers Look at Compensation for Ailing 9/11 Volunteers
- Toyota to Pay More Than $1 Billion to Resolve Class Action Lawsuit
- Will Show Me State Show Injustice to Mesothelioma Victims?
- Landowner Class Action Lawsuit Has Led to Multiple Settlements Across Country
Categories
Archives
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
Monthly Archives: March 2012
The Way Suing Should Be?
Reuters reported on March 21, 2012, that a class action lawsuit has been filed in California alleging CarMax, Inc. failed to pay certain workers overtime in violation of federal and California overtime pay laws. The lawsuit charges that CarMax and certain subsidiaries “have a common, uniform practice of misclassifying its buyers as exempt and failing to pay them for all overtime hours worked.” “CarMax’s great success in the used vehicle sales market rests in part on the hard work and long hours of its dedicated buyers,” plaintiff Mike Luchini said in a press release. “We work through early mornings, meal times, and late evenings for the company. We just ask to be paid for the hours we have worked, according to what the law requires.” The lawsuit is seeking “fair compensation for CarMax’s roughly 1,500 buyers nationwide” by recovering overtime pay for the hours the employees have worked in recent…
Read More »
Posted in Class Actions
Tagged carmax, class action lawsuit, class action lawyers, fortune 500, overtime pay laws
Leave a comment
Mountaineer Survived Everest, But Not Mesothelioma
The Associated Press reported that mountaineer Lincoln Hall expressed no resentment about being left near the summit of the highest mountain the world in 2006. Hall reached the peak of Mount Everest but became gravely ill because of oxygen deprivation during the descent. While his own guides helped him initially, they left to save their own lives and, incredibly, American guide Daniel Mazur, his two clients and a Sherpa guide found Hall the next day two hours from the peak. “I was shocked to see a guy without gloves, hat, oxygen bottles or sleeping bag at sunrise at 28,200 feet height, just sitting up there,” Mazur told the AP after the rescue. Hall survived being given up for dead near the top of Everest, but he died at the age of 56 on March 21, 2012, in Australia one year after being diagnosed with mesothelioma. The AP said he was…
Read More »
Schwab-Finra Outcome Could Affect Other Class Actions Against Brokerages
There could be an important ruling about class action lawsuits coming out of a U.S. district court next month when Charles Schwab and the Financial Industry Regulatory Authority (Finra) next meet. The Wall Street Journal reported on March 16, 2012, that the two sides are currently in a dispute over whether investors should be allowed to bring class action lawsuits against brokerages. Investors opening brokerage accounts typically agree not to sue the broker, instead settling disputes through an arbitration process run by the industry-funded Finra, according to the Journal. The problem for Finra is not only does it not have an arbitration process for class action claims, but it claims that its rules prohibit brokerages from making customers agree to waiving their class action rights. The Journal reported that Schwab added a class action waiver to its customer agreements in September, and is citing an April U.S. Supreme Court decision that…
Read More »
Gene Therapy Clinical Trial Gives Hope to Mesothelioma Victims
As we discussed on Monday, Dr. Daniel Sterman discussed some very encouraging results from a gene therapy clinical trial at the University of Pennsylvania School of Medicine that could give hope to millions of mesothelioma victims and their families. In addition to calling the crude data from the trial “very, very impressive,” Sterman also spoke about how gene therapy affected some of the mesothelioma patients. “We had one [recently] with a 75 percent reduction in the tumor,” Sterman said, according to Asbestos.com. “[In this trial] we can provide all the benefits of standard therapy, along with the exciting prospects of genetic therapy.” Sterman spoke about one patient who, 14 years after an early version of gene therapy, needs help only for an occasional bout with pleural inflammation. Asbestos.com reported that because of gene therapy, the patient’s own immune system has “kept the mesothelioma in check.” Sterman also talked about another…
Read More »